IDXX Stock Analysis: Buy, Sell, or Hold?
IDXX - Idexx Laboratories Inc
$545.73
-16.36 (-2.91%)
▼
5d:
-2.7%
30d:
-1.42%
90d:
-5.46%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When IDXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IDXX shows positive signals but monitor for confirmation. Market pricing in 5.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: IDXX shows positive signals but monitor for confirmation. Market pricing in 5.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$618.12
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$383.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IDXX is currently trading at $545.73, which is considered oversold relative to its 30-day fair value range of $547.41 to $568.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 33.0) compared to its historical average (39.5). Remarkably, the market is currently pricing in an annual earnings decline of 5.8% over the next few years. This pessimistic expectation contrasts with the company's recent 17.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IDXX is in a strong downtrend. The price is currently testing key support at $543.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IDXX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $709.14 (+29.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IDXX is in a strong downtrend. The price is currently testing key support at $543.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IDXX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $709.14 (+29.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$547.41 -
$568.17
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.9% below Wall St target ($709.14)
Trading Range Analysis
30-Day Trading Range
$547.41 -
$568.17
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$16.42
(3.0%)
Support & Resistance Levels
Support Level
$543.89
Resistance Level
$581.47
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.04
Wall Street Target
$709.14
(+29.9%)
Revenue Growth (YoY)
14.3%
Earnings Growth (YoY)
17.2%
Profit Margin
24.6%
Valuation Discount vs History
-5.8% cheaper
PE vs Historical
33.0 vs 39.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.8%
(market-implied from PE analysis)
1-Year Target
$514.08
(-6%)
2-Year Target
$484.26
(-11%)
3-Year Target
$456.17
(-16%)
3-Yr Target (if PE normalizes)
(PE: 33→40)
$545.32
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.0, Growth: 12.9%)
$785.94
(+44%)
Base:
(SPY PE: 21.8, Growth: 12.9%)
$518.05
(-5%)
Bear:
(PE: 18.5, Growth: 12.9%)
$440.34
(-19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 41.33 | Current EPS (TTM): $13.60
Bull Case
$750.86
(+38%)
Analyst growth 21.4%, PE expands to 45.5
Base Case
$682.60
(+25%)
Market implied 21.4%, PE stable at 41.3
Bear Case
$382.22
(-30%)
Severe decline -20.0%, PE contracts to 35.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 33.0 to 39.5
Stabilization Target:
$652.38
(+19.5%)
PE Expansion Potential:
+19.5%
Share & Embed Analysis
Last updated: June 23, 2026 2:49 AM ET
Data refreshes hourly during market hours. Next update: 3:49 AM
Data refreshes hourly during market hours. Next update: 3:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IDXX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Nimrata Hunt
SELL
1758 shares
2026-03-03
Jonathan Jay Mazelsky
SELL
23326 shares
2026-02-26
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
Advanced IDXX Option Strategies
Professional options setups generated by AI based on today's IDXX price and gamma walls.
